ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 190 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,233,340 | -15.2% | 702,900 | +19.1% | 0.01% | -20.0% |
| Q2 2023 | $3,813,338 | -6.4% | 590,300 | +9.2% | 0.01% | -9.1% |
| Q1 2023 | $4,074,616 | -36.0% | 540,400 | -14.1% | 0.01% | -38.9% |
| Q4 2022 | $6,369,744 | +37.7% | 628,800 | +34.4% | 0.02% | +38.5% |
| Q3 2022 | $4,626,000 | +817.9% | 467,700 | +888.8% | 0.01% | +1200.0% |
| Q2 2022 | $504,000 | +111.8% | 47,300 | +93.9% | 0.00% | 0.0% |
| Q1 2022 | $238,000 | -66.3% | 24,400 | +17.3% | 0.00% | -50.0% |
| Q1 2021 | $706,000 | – | 20,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $38,225,859 | 94.47% |
| Founders Fund Growth Management, LLC | 407,017 | $4,123,082 | 20.66% |
| Gruss & Co., LLC | 255,400 | $2,587,202 | 15.98% |
| Belmont Capital, LLC | 510,000 | $5,166 | 5.52% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $41,584,612 | 5.16% |
| Intellectus Partners, LLC | 868,583 | $8,798,743 | 3.06% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $18,221,423 | 2.07% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $577,167 | 2.02% |
| Prosight Management, LP | 322,754 | $3,269,498 | 1.78% |
| Casdin Capital, LLC | 2,270,000 | $22,995,100 | 1.78% |